Roivant Sciences LTD. (ROIV) — 10-Q Filings

All 10-Q filings from Roivant Sciences LTD.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Roivant's Revenue Plummets 65% Amidst Deepening Losses — Nov 10, 2025 Risk: high
Roivant Sciences Ltd. reported a significant decrease in revenue for the three months ended September 30, 2025, falling to $1.571 million from $4.475 million in
Roivant Narrows Q1 Loss to $150.5M on Cost Cuts, Revenue Growth — Aug 11, 2025 Risk: medium
Roivant Sciences Ltd. (ROIV) reported a net loss of $150.5 million for the quarter ended June 30, 2025, a significant improvement from the $250.0 million net lo
Roivant Sciences Files Q3 2024 10-Q — Feb 10, 2025 Risk: medium
Roivant Sciences Ltd. filed its 10-Q for the period ending December 31, 2024. The company reported financial results for the third quarter and the first nine mo
Roivant Sciences Files Q2 2024 10-Q — Nov 12, 2024 Risk: medium
Roivant Sciences Ltd. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the second quarter and the first half
Roivant Sciences Q1 Revenue Surges, R&D Costs Climb — Aug 9, 2024 Risk: medium
Roivant Sciences Ltd. filed its 10-Q for the period ending June 30, 2024. The company reported License, Milestone, and Other Revenue of $100.5 million for the f
Roivant Sciences Ltd. Files 10-Q for Period Ending December 31, 2023 — Feb 13, 2024 Risk:
Roivant Sciences Ltd. (ROIV) filed a Quarterly Report (10-Q) with the SEC on February 13, 2024. Roivant Sciences Ltd. filed its 10-Q report for the period endin

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX